Fumarate therapies are equally effective among Black, Hispanic, Asian, and white people with relapsing forms of MS, a real-world study shows.

Fenebrutinib significantly reduced new lesions with active inflammation in people with relapsing MS in a Phase 2 trial.

Columnist Ahna Crum, who's a practitioner in functional medicine, questioned herself when she had an unexpected MS relapse.

Regular exercise that follows established guidelines for physical activity in MS lead to clinically meaningful improvements ...

A six-week music-based intervention may reduce psychosocial fatigue and heat pain sensitivity in people with multiple ...

An international Phase 2 trial will test BMS-986368 as a potentially new oral therapy for managing multiple sclerosis-related ...

A person's total number of visits to multiple sclerosis clinics is not associated with a lower risk of death, a study on ...

To clarify aspects of multiple sclerosis that might be confusing, columnist Ben Hofmeister tries to use humor, analogies, and metaphors.

Researchers have developed a blood test to predict MS onset by measuring EBV antibody levels, potentially allowing early diagnosis and care.

Columnist Desiree Lama shares some of the difficulties she faces when she travels with MS, such as fatigue and body aches.